Please assess the completion status of the following clinical trial:

Trial Title: Novel Surrogate Markers as Predictors of Radiation Toxicity in Breast Cancer Patients Undergoing Helical Tomotherapy Compared to Standard Radiation Therapy

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* early breast cancer treated with lumpectomy~* must have T1-2 N0-1 invasive carcinoma of the breast~* must sign an informed consent~* must be at least 18 years of age~Exclusion Criteria:~* collagen vascular disease~* metastatic disease~* pregnant or lactating

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).